Publications and Presentations Database
]
(2016). Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial..
Annals of internal medicine. 164(3), 155-63. Abstract
(2018). A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone..
Genetics in medicine : official journal of the American College of Medical Genetics. 20(1), 132-41. Abstract
